Impact of inappropriate empirical antibiotic treatment on clinical outcomes of urinary tract infections caused by Escherichia coli: a retrospective cohort study

被引:14
|
作者
Zhu, Hongying [1 ]
Chen, Yanhui [1 ]
Hang, Yaping [1 ]
Luo, Hong [1 ]
Fang, Xueyao [1 ]
Xiao, Yanping [1 ]
Cao, Xingwei [1 ]
Zou, Shan [1 ]
Hu, Xiaoyan [1 ]
Hu, Longhua [1 ]
Zhong, Qiaoshi [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Prov Key Lab Med, Clin Lab, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Inappropriate empirical antibiotic treatment; Urinary tract infection; Escherichia coli; Fluoroquinolones; CIPROFLOXACIN; GUIDELINES; THERAPY;
D O I
10.1016/j.jgar.2021.05.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to determine the clinical impact of inappropriate empirical antibiotic treatment (IEAT) compared with appropriate empirical antibiotic treatment (AEAT) in hospitalised patients with urinary tract infections (UTIs) caused by Escherichia coli (E. coli). Methods: This retrospective cohort study included adult patients with a primary diagnosis of UTI who were treated with empirical antibiotics at a tertiary hospital in southern China over a 2-year period. Clinical data of patients who received IEAT were compared with those of patients receiving AEAT. We used multivariable logistic regression to identify the predictors for receiving IEAT and the risk factors affecting clinical outcomes. Results: A total of 213 patients were enrolled (median age, 61 years), of whom 103 (48.4%) received IEAT. IEAT was associated with empirical use of fluoroquinolones, male sex and age-adjusted Charlson comorbidity index (aCCI) score > 6. Hospital length of stay (LOS) was longer for patients who received IEAT than for those who received AEAT (13.6 +/- 8.6 days vs. 10.8 +/- 7.9 days; P = 0.008). IEAT was an independent risk factor for longer LOS along with aCCI score >= 2, lung disease and cardiac disease. Conclusion: Empirical use of fluoroquinolones for UTIs should be avoided, especially in male patients with aCCI score > 6. Improved empirical antimicrobial therapy may have a beneficial impact in reducing bacterial resistance and healthcare costs by decreasing the LOS. Therefore, interventions to promote indepth antibiotic stewardship programmes in China are needed. (C) 2021 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [1] Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort
    Alexander, Bryan T.
    Marschall, Jonas
    Tibbetts, Robert J.
    Neuner, Elizabeth A.
    Dunne, W. Michael, Jr.
    Ritchie, David J.
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1314 - 1323
  • [2] Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study
    Esteve-Palau, E.
    Solande, G.
    Sanchez, F.
    Sorli, L.
    Montero, M.
    Gueerri, R.
    Villar, J.
    Grau, S.
    Horcajada, J. P.
    JOURNAL OF INFECTION, 2015, 71 (06) : 667 - 674
  • [3] Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study
    Ahmed, Haroon
    Farewell, Daniel
    Francis, Nick A.
    Paranjothy, Shantini
    Butler, Christopher C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (06) : 857 - 866
  • [4] Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study
    Greenhouse, Inbal
    Babushkin, Frida
    Finn, Talya
    Shimoni, Zvi
    Aliman, Moran
    Ben-Ami, Ronen
    Cohen, Regev
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (03) : 222 - 229
  • [5] Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains
    Zalewska-Piatek, Beata
    Piatek, Rafal
    ACTA BIOCHIMICA POLONICA, 2019, 66 (02) : 129 - 138
  • [6] Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options
    Zhou, Yang
    Zhou, Zuying
    Zheng, Lin
    Gong, Zipeng
    Li, Yueting
    Jin, Yang
    Huang, Yong
    Chi, Mingyan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [7] Clinician Distress and Inappropriate Antibiotic Prescribing for Acute Respiratory Tract Infections: A Retrospective Cohort Study
    Brady, Keri J. S.
    Barlam, Tamar F.
    Trockel, Mickey T.
    Ni, Pengsheng
    Sheldrick, R. Christopher
    Schneider, Jeffrey I.
    Rowe, Susannah G.
    Kazis, Lewis E.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2022, 48 (05): : 287 - 297
  • [8] Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study
    Bollestad, Marianne
    Grude, Nils
    Solhaug, Sigrid
    Raffelsberger, Niclas
    Handal, Nina
    Nilsen, Hans-Johnny Schjelderup
    Romstad, Monica Regine
    Emmert, Andreas
    Tveten, Yngvar
    Soraas, Arne
    Jenum, Pal A.
    Jenum, Synne
    Moller-Stray, Janne
    Weme, Einar Tollaksen
    Lindbaek, Morten
    Simonsen, Gunnar Skov
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2503 - 2509
  • [9] Fosfomycin:: an underrated antibiotic for urinary tract infections due to Escherichia coli
    Garau, M
    Latorre, A
    Alonso-Sanz, M
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (10): : 462 - 466
  • [10] Clinical and pylogenetic characteristics of Escherichia coli urinary tract infections
    Lee, S. Y.
    Kim, J. H.
    Hur, J. K.
    Kang, J. H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E221 - E221